Oncolytics is developing pelareorep, an IV delivered I-O agent, which introduces double-stranded RNA into cancer cells.
Contact company: bit.ly/371iOaq

ID: 25760403

linkhttp://www.oncolyticsbiotech.com calendar_today22-03-2009 01:29:42